| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vivos Therapeutics, Inc. (VVOS) has 1 insider with recent SEC Form 4 filings, including 3 buys and 0 sells. VVOS is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.04M | $903.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 24, 2020 | Amman Bradford K. | Chief Financial Officer | Buy | 1,000 | $7.38 | $7,380.00 | New | |
| Dec 23, 2020 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 1,000 | $7.27 | $7,266.90 | +200.0% | |
| Dec 11, 2020 | Huntsman Ronald Kirk | Chief Executive Officer | Buy | 500 | $8.50 | $4,250.00 | New |